Grupa Prosper sees 1st qtr profit of $1.3M

28 May 2006

Polish pharmaceuticals distributor Grupa Prosper says that its net profit totaled 3.8 million zloty ($1.26 million) in the first quarter of 2006, sky-rocketing 72.7% on the like, year-ago period, according to the Interfax news agency. During the reported quarter, its sales revenue grew 10% to 490.0 million zloty.

The Warsaw-headquartered company noted that its first quarter revenue growth out stripped P oland's drugs distribution market as a whole, pointing out that it controls approximately 10% of the sector.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight